- £170.23m
- £204.13m
- £178.47m
- 78
- 47
- 21
- 44
2019 August 31st | 2020 August 31st | 2021 August 31st | 2022 August 31st | 2023 August 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 84.7 | 130 | 174 | 184 | 178 |
Cost of Revenue | |||||
Gross Profit | 35.8 | 59.9 | 84.1 | 83.3 | 84.8 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 71.9 | 122 | 138 | 155 | 154 |
Operating Profit | 12.8 | 7.93 | 35.8 | 28.7 | 24.3 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 13 | 7.03 | 35 | 30.5 | 22.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | 11.7 | 4.09 | 28.3 | 24.8 | 17.8 |
Net Income Before Extraordinary Items | |||||
Net Income | 11.7 | 4.09 | 28.3 | 24.8 | 17.8 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 11.7 | 4.09 | 28.3 | 24.8 | 17.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.212 | 0.19 | 0.504 | 0.433 | 0.327 |
Dividends per Share |